The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine

Journal of Ethnopharmacology

Volumn 117, Issue 1, 2008, Pages 158-165

  Shu, Haihua ^a,c   Hayashida, Masakazu ^b   Huang, Wenqi ^a   An, Ke ^a   Chiba, Shunsuke ^c   Hanaoka, Kazuo ^c   Arita, Hideko ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Kappa opioid receptor; Morphine tolerance; NMDA receptor; Processed Aconiti tuber

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ACONITUM EXTRACT; DIZOCILPINE; HERBACEOUS AGENT; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORBINALTORPHIMINE; PLACEBO; PROCESSED ACONITI TUBER; UNCLASSIFIED DRUG; WATER;

ACONITUM; ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG TOLERANCE; HERBAL MEDICINE; HOT PLATE TEST; MALE; NONHUMAN; PAIN THRESHOLD; THERMAL ANALYSIS;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ACONITUM; ANALGESICS, OPIOID; ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; MICE; MORPHINE; NALTREXONE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, KAPPA;

MUS;

EID: 40949120502     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.01.029     Document Type: Article

References (43)

1. Ameri A. The effect of aconitum alkaloids on the central nervous system. Progress in Neurobiology 56 (1998) 211-235
2. Bhargava H.N. Drugs that modify opioid tolerance, physical dependence, and abstinence symptoms: preclinical and clinical studies. NIDA Research Monograph 147 (1995) 53-83
3. Bie B., and Pan Z.Z. Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors. Journal of Neuroscience (2003) 7262-7268
4. Bohn L.M., Lefkowitz R.J., Gainetdinov R.R., Peppel K., Caron M.G., and Lin F.T. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286 (1999) 2495-2498
5. Bossard A.E., Guirimand F., Fletcher D., Gaude-Joindreau V., Chauvin M., and Bouhassira D. Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 98 (2002) 47-57
6. Dortch-Carnes J., and Potter D.E. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Reviews 11 (2005) 195-212
7. Fundytus M.E. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15 (2001) 29-58
8. Gonzalez P., Cabello P., Germany A., Norris B., and Contreras E. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. European Journal of Pharmacology 332 (1997) 257-262
9. Grace R.F., Power I., Umedaly H., Zammit A., Mersiades M., Cousins M.J., and Mather L.E. Preoperative dextromethorphan reduces intraoperative but not postoperative morphine requirements after laparotomy. Anesthesia & Analgesia 87 (1998) 1135-1138
10. Green P.G., and Lee N.M. Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. European Journal of Pharmacology 145 (1988) 267-272
11. Greenwald M.K., Stitzer M.L., and Haberny K.A. Human pharmacology of the opioid neuropeptide dynorphin A(1-13). Journal of Pharmacology and Experimental Therapeutics 281 (1997) 1154-1163
12. Hao S., Mamiya K., Takahata O., Iwasaki H., Mata M., and Fink D.J. Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats. Anesthesia & Analgesia 96 (2003) 1065-1071
13. Inturrisi C.E. preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence. Seminars in Neuroscience 9 (1997) 110-119
14. Inturrisi C.E. The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance. Minerva Anestesiologica 71 (2005) 401-403
15. Kreek M.J., Schluger J., Borg L., Gunduz M., and Ho A. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. Journal of Pharmacology and Experimental Therapeutics 288 (1999) 260-269
16. Mao J., Price D.D., and Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62 (1995) 259-274
17. Mercadante S., Arcuri E., Tirelli W., and Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. Journal of Pain Symptom Management 20 (2000) 246-252
18. Murayama M., Mori T., Bando H., and Amiya T. Studies on the constituents of Aconitum species. IX. The pharmacological properties of pyro-type aconitine alkaloids, components of the processed aconite powder 'kako-bushi-matsu': analgesic, anti-inflammatory, and acute toxic activities. Journal of Ethnopharmacology 35 (1991) 159-164
19. Omiya Y., Goto K., Suzuki Y., Ishige A., and Komatsu Y. The analgesia-producing mechanism of processed Aconiti tuber: role of dynorphin, an endogenous kappa-opioid ligand, in rodent spinal cord. The Japanese Journal of Pharmacology 79 (1999) 295-301
20. Pan Z.Z. mu-Opposing actions of kappa-opioid receptor. Trends in Pharmacological Sciences 19 (1998) 94-98
21. Pfeiffer A., Brantl V., Herz A., and Emrich H.M. Psychotomimesis mediated by κ opiate receptors. Science 233 (1986) 774-776
22. Popik P., Kozela E., and Danysz W. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 361 (2000) 425-432
23. Shimoyama N., Shimoyama M., Inturrisi C.E., and Elliott K.J. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 85 (1996) 1357-1366
24. Shippenberg T.S., and Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacology, Biochemistry, and Behavior 57 (1997) 449-455
25. Shirasaki S., Minamoto N., and Tsukada S. The analgesic effect of 'Bushi' powder, and combined with epidural nerve block, for chronic back and leg pain in aged patients. Pain and Kampo Medicine 9 (1999) 23-26 (Abstract in English, Article in Japanese)
26. Shu H., Arita H., Hayashida M., Sekiyama H., and Hanaoka K. Effects of processed Aconiti tuber and its ingredient alkaloids on the development of antinociceptive tolerance to morphine. Journal of Ethnopharmacology 103 (2006) 398-405
27. Shu H., Arita H., Hayashida M., Chiba S., Sekiyama H., and Hanaoka K. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors. Journal of Ethnopharmacology 106 (2006) 263-271
28. Shu H., Hayashida M., Chiba S., Sekiyama H., Kitamura T., Yamada Y., Hanaoka K., and Arita H. Inhibitory effect of processed Aconiti tuber on the development of antinociceptive tolerance to morphine: evaluation with a thermal assay. Journal of Ethnopharmacology 113 (2007) 560-563
29. Song Z.H., and Takemori A.E. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception. Life Sciences 48 (1991) 1447-1453
30. Specker S., Wananukul W., Hatsukami D., Nolin K., Hooke L., Kreek M.J., and Pentel P.R. Effects of dynorphin A(1-13) on opiate withdrawal in humans. Psychopharmacology (Berl) 137 (1998) 326-332
31. Subramaniam K., Subramaniam B., and Steinbrook R.A. Ketamine as an adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesthesia & Analgesia 99 (2004) 482-495
32. Suzuki Y., Goto K., Ishige A., Komatsu Y., and Kamei J. Antinociceptive effect of Gosha-jinki-gan, a Kampo medicine, in streptozotocin-induced diabetic mice. The Japanese Journal of Pharmacology 79 (1999) 169-175
33. Takahashi M., Senda T., and Kaneto H. Role of spinal κ-opioid receptors in blockade of the development of antinociceptive tolerance to morphine. European Journal of Pharmacology 200 (1991) 293-297
34. Taki M., Omiya Y., Suzuki Y., Ikeda Y., Noguchi M., Matuba T., Kubo M., Niitu K., Komatsu Y., and Okada M. Quality and pharmacological investigation of processed Aconiti Tuber (TJ-3022). Natural Medicines 52 (1998) 343-352 (Abstract in English, Article in Japanese)
35. Tokuyama S., Nagae R., Mashida E., and Hamabe W. Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice. The Journal of Pharmacy and Pharmacology 59 (2007) 1109-1115
36. Trujillo K.A. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl. ) 151 (2000) 121-141
37. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
38. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annual Review of Biochemistry 73 (2004) 953-990
39. Walsh S.L., Strain E.C., Abreu M.E., and Bigelow G.E. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology 157 (2001) 151-162
40. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?. Drugs 55 (1998) 1-4
41. Xu H., Arita H., Hayashida M., Zhang L., Sekiyama H., and Hanaoka K. Pain-relieving effects of processed Aconiti tuber in CCI-neuropathic rats. Journal of Ethnopharmacology 103 (2006) 392-397
42. Yu J., Butelman E.R., Woods J.H., Chait B.T., and Kreek M.J. Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics 282 (1997) 633-638
43. Zeng J., Thomson L.M., Aicher S.A., and Terman G.W. Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats. Journal of Neuroscience 26 (2006) 12033-12042